89 related articles for article (PubMed ID: 37036605)
41. Exosome-Induced Regulation in Inflammatory Bowel Disease.
Zhang H; Wang L; Li C; Yu Y; Yi Y; Wang J; Chen D
Front Immunol; 2019; 10():1464. PubMed ID: 31316512
[TBL] [Abstract][Full Text] [Related]
42. Effect of Simvastatin on the Intestinal Rho/ROCK Signaling Pathway in Rats With Sepsis.
Wang Y; Wang X; Yang W; Zhao X; Zhang R
J Surg Res; 2018 Dec; 232():531-538. PubMed ID: 30463769
[TBL] [Abstract][Full Text] [Related]
43. Preconditioning influences mesenchymal stem cell properties in vitro and in vivo.
Hu C; Li L
J Cell Mol Med; 2018 Mar; 22(3):1428-1442. PubMed ID: 29392844
[TBL] [Abstract][Full Text] [Related]
44. EphrinB1 promotes cancer cell migration and invasion through the interaction with RhoGDI1.
Cho HJ; Hwang YS; Yoon J; Lee M; Lee HG; Daar IO
Oncogene; 2018 Feb; 37(7):861-872. PubMed ID: 29059157
[TBL] [Abstract][Full Text] [Related]
45. The intestinal barrier: a fundamental role in health and disease.
Vancamelbeke M; Vermeire S
Expert Rev Gastroenterol Hepatol; 2017 Sep; 11(9):821-834. PubMed ID: 28650209
[TBL] [Abstract][Full Text] [Related]
46. The Protective Roles of ROS-Mediated Mitophagy on
Hu L; Wang H; Huang L; Zhao Y; Wang J
Oxid Med Cell Longev; 2016; 2016():9460462. PubMed ID: 28119765
[TBL] [Abstract][Full Text] [Related]
47. The intestinal epithelial barrier: a therapeutic target?
Odenwald MA; Turner JR
Nat Rev Gastroenterol Hepatol; 2017 Jan; 14(1):9-21. PubMed ID: 27848962
[TBL] [Abstract][Full Text] [Related]
48. Mechanisms of Intestinal Barrier Dysfunction in Sepsis.
Yoseph BP; Klingensmith NJ; Liang Z; Breed ER; Burd EM; Mittal R; Dominguez JA; Petrie B; Ford ML; Coopersmith CM
Shock; 2016 Jul; 46(1):52-9. PubMed ID: 27299587
[TBL] [Abstract][Full Text] [Related]
49. Immunomodulatory effects of mesenchymal stromal cells-derived exosome.
Chen W; Huang Y; Han J; Yu L; Li Y; Lu Z; Li H; Liu Z; Shi C; Duan F; Xiao Y
Immunol Res; 2016 Aug; 64(4):831-40. PubMed ID: 27115513
[TBL] [Abstract][Full Text] [Related]
50. Therapeutic applications of extracellular vesicles: clinical promise and open questions.
György B; Hung ME; Breakefield XO; Leonard JN
Annu Rev Pharmacol Toxicol; 2015; 55():439-464. PubMed ID: 25292428
[TBL] [Abstract][Full Text] [Related]
51. Eph receptors and ephrins: therapeutic opportunities.
Barquilla A; Pasquale EB
Annu Rev Pharmacol Toxicol; 2015; 55():465-87. PubMed ID: 25292427
[TBL] [Abstract][Full Text] [Related]
52. Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease.
Renna S; Cottone M; Orlando A
World J Gastroenterol; 2014 Aug; 20(29):9675-90. PubMed ID: 25110407
[TBL] [Abstract][Full Text] [Related]
53. Eph receptor signaling and ephrins.
Lisabeth EM; Falivelli G; Pasquale EB
Cold Spring Harb Perspect Biol; 2013 Sep; 5(9):. PubMed ID: 24003208
[TBL] [Abstract][Full Text] [Related]
54. Exosomes: mediators of neurodegeneration, neuroprotection and therapeutics.
Kalani A; Tyagi A; Tyagi N
Mol Neurobiol; 2014 Feb; 49(1):590-600. PubMed ID: 23999871
[TBL] [Abstract][Full Text] [Related]
55. Innate and adaptive immunity in inflammatory bowel disease.
Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
[TBL] [Abstract][Full Text] [Related]
56. EphB and Ephrin-B interactions mediate human mesenchymal stem cell suppression of activated T-cells.
Nguyen TM; Arthur A; Hayball JD; Gronthos S
Stem Cells Dev; 2013 Oct; 22(20):2751-64. PubMed ID: 23711177
[TBL] [Abstract][Full Text] [Related]
57. Pre-treatment with IL-1β enhances the efficacy of MSC transplantation in DSS-induced colitis.
Fan H; Zhao G; Liu L; Liu F; Gong W; Liu X; Yang L; Wang J; Hou Y
Cell Mol Immunol; 2012 Nov; 9(6):473-81. PubMed ID: 23085948
[TBL] [Abstract][Full Text] [Related]
58. A novel feedback mechanism by Ephrin-B1/B2 in T-cell activation involves a concentration-dependent switch from costimulation to inhibition.
Kawano H; Katayama Y; Minagawa K; Shimoyama M; Henkemeyer M; Matsui T
Eur J Immunol; 2012 Jun; 42(6):1562-72. PubMed ID: 22622783
[TBL] [Abstract][Full Text] [Related]
59. IL1β induces mesenchymal stem cells migration and leucocyte chemotaxis through NF-κB.
Carrero R; Cerrada I; Lledó E; Dopazo J; García-García F; Rubio MP; Trigueros C; Dorronsoro A; Ruiz-Sauri A; Montero JA; Sepúlveda P
Stem Cell Rev Rep; 2012 Sep; 8(3):905-16. PubMed ID: 22467443
[TBL] [Abstract][Full Text] [Related]
60. Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation.
François M; Romieu-Mourez R; Li M; Galipeau J
Mol Ther; 2012 Jan; 20(1):187-95. PubMed ID: 21934657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
